Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001193125-24-200225
Filing Date
2024-08-14
Accepted
2024-08-14 07:10:56
Documents
2

Document Format Files

Seq Description Document Type Size
1 425 d879192d425.htm 425 66523
2 GRAPHIC g879192g0813023223261.jpg GRAPHIC 3604
  Complete submission text file 0001193125-24-200225.txt   73317
Mailing Address 45 LIBERTY BLVD. SUITE 230 MALVERN PA 19355
Business Address 45 LIBERTY BLVD. SUITE 230 MALVERN PA 19355 610-725-1500
Galera Therapeutics, Inc. (Filed by) CIK: 0001563577 (see all company filings)

EIN.: 461454898 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 45 LIBERTY BLVD. SUITE 230 MALVERN PA 19355
Business Address 45 LIBERTY BLVD. SUITE 230 MALVERN PA 19355 610-725-1500
Galera Therapeutics, Inc. (Subject) CIK: 0001563577 (see all company filings)

EIN.: 461454898 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-39114 | Film No.: 241204126
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)